Baseline LDH as a prognostic biomarker of early treatment failure in lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...

DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced that researchers from NYU Langone Health, in ...

Model and clinical segmentation examples. (A) 71-year-old female with non-small cell lung cancer (NSCLC) from the internal test set. (B) 87-year-old male with NSCLC from the external test set. Both ...

Results of an artificial intelligence–based tool to predict financial toxicity early to facilitate early referral to hospital social workers. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...

BioMark Diagnostics ( ($TSE:BUX) ) has provided an announcement. BioMark Diagnostics Inc. and its research partners have been honored with the ...

Detailed price information for Biomark Diagnostics Inc (BUX-CN) from The Globe and Mail including charting and trades.

While the U.S. election dominated global headlines, there has been lots of other news you may have missed, including Microsoft researchers who detected lung cancer risks through web search logs, and ...

Please provide your email address to receive an email when new articles are posted on . Machine learning models can predict which patients receiving lung cancer therapy may need urgent care visits.